Electric current delivers lutein to eyes in AMD study

This study looked at whether a treatment called transscleral lutein iontophoresis (TSLI) is safe and helpful for people with a specific type of age-related macular degeneration (AMD) that includes reticular pseudodrusen. Thirty participants received the treatment, and their vision and eye health were checked at 1 and 3 months. The goal was to see if this approach could improve vision or slow disease changes.